Today, ACI joined 70 other organizations in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi. The bill would impose excise taxes up to 95% on hundreds of prescription medicines. You can read the coalition letter online. 10-15-19 Coalition Letter Opposed to Pelosi Drug Tax Plan
In May 2018, the Federal Bureau of Investigation (FBI) published a warning notifying that Russian computer hackers had compromised hundreds of thousands of home and office routers and could collect user information or shut down network traffic. The Bureau then urged the owners of several brands of routers to turn them off and on again, and […]
Today, ACI joins a 14 nonprofit organizations representing both consumers and taxpayers in sending a letter to the Acting Commissioner, Norman Sharpless. This letter calls for the FDA to release its data from the 2019 National Youth Tobacco Survey before moving any further with the proposed ban on vaping products. The public deserves to know […]
Today, ACI joined a group of think tanks, consumer and tax groups urging the President to protect adult vapers by keeping flavored products legally available. The letter is available online.
The following statement can be attributed to Steve Pociask, President of the American Consumer Institute, regarding today’s decision by the D.C. Circuit Court of Appeals on the Mozilla v. FCC case: “Today, the D.C. Circuit Court upheld the FCC’s latest order to keep an open and free Internet, instead of reverting back to onerous 1930’s […]
On September 25, 2019, the American Consumer Institute held a policy briefing called “Pricing Policy Prescriptions for 2020: The Good, The Bad, and The Ugly.” The event included guest speaker John Fund, along with the following policy experts: Krisztina Pusok, Director of Policy and Research at the American Consumer Institute (moderating); Robert Graboyes is a Senior […]
Fourteen nonprofit organizations sent a letter to President Trump urging him not to pursue an Executive Order to forgive Venezuela for its debts to private citizens and companies. You can read the coalition letter here.
Senate Russell Office Building Featured Keynote Speaker: John Fund Topic: Escalating drug prices are generating a fierce political and policy debate. Join the American Consumer Institute on September 25th for a distinguished panel of experts who will discuss recent proposals put forth in Congress and the White House to address increasing prescription drug costs. Hear […]
While the Lower Health Care Costs Act is intended to increase competition and patient access to lower cost medicines, section 205 of the bill needs to address FDA concerns about the “parking” of generic applications. We believe generic manufacturers need to launch new medications into the market as soon as possible after approval. However, as […]